COMMUNIQUÉS West-GlobeNewswire

Aclaris Therapeutics Reports Third Quarter 2018 Financial Results and Provides Update on Clinical and Commercial Developments
06/11/2018
Management to Host Conference Call at 5:00 PM ET today WAYNE, Pa., Nov. 06, 2018 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ:ACRS), a dermatologist-led biopharmaceutical company focused on identifying, [...]
Principia Biopharma Reports Third Quarter Financial Results
06/11/2018
SOUTH SAN FRANCISCO, Calif., Nov. 06, 2018 (GLOBE NEWSWIRE) -- Principia Biopharma Inc. (Nasdaq: PRNB), a clinical-stage biopharmaceutical company dedicated to bringing transformative oral therapies to patients with [...]
Immune Design Reports Third Quarter 2018 Financial Results and Provides Corporate Update
06/11/2018
Conference call at 1:30 pm Pacific today SEATTLE and SOUTH SAN FRANCISCO, Calif., Nov. 06, 2018 (GLOBE NEWSWIRE) -- Immune Design (Nasdaq: IMDZ), an immunotherapy company focused on next-generation therapies in oncology [...]
Cara Therapeutics Reports Third Quarter 2018 Financial Results
06/11/2018
– Conference call today at 4:30 p.m. ET – STAMFORD, Conn., Nov. 06, 2018 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA), a biopharmaceutical company focused on developing and commercializing new chemical [...]
Allena Pharmaceuticals to Present at Upcoming Investor Conferences in November
06/11/2018
NEWTON, Mass., Nov. 06, 2018 (GLOBE NEWSWIRE) -- Allena Pharmaceuticals, Inc. (NASDAQ:ALNA), a late-stage biopharmaceutical company dedicated to developing and commercializing first-in-class, oral enzyme therapeutics to [...]
Sientra Reports Third Quarter 2018 Financial Results
06/11/2018
Achieves Total Net Sales of $16.9 Million, Pro Forma Growth of 58% YoY, 72% on a GAAP Basis Record miraDry Net Sales of $8.3 Million, Pro Forma Growth of 174% YoY, 282% on a GAAP Basis Initiates International Expansion [...]
Xenon Pharmaceuticals Reports Third Quarter 2018 Financial Results and Provides Corporate Update
06/11/2018
Robust, Novel Pipeline of Neurology Candidates Advancing in Clinical Development Conference Call at 4:30 pm ET Today BURNABY, British Columbia, Nov. 06, 2018 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE [...]
Iovance Biotherapeutics Reports Third Quarter 2018 Financial Results and Provides Corporate Update
06/11/2018
Company to Host Conference Call at 4:30pm ET Today SAN CARLOS, Calif., Nov. 06, 2018 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a biotechnology company developing novel cancer immunotherapies [...]
Bellicum Pharmaceuticals Reports Third Quarter 2018 Financial Results and Provides Corporate Update
06/11/2018
HOUSTON, Nov. 06, 2018 (GLOBE NEWSWIRE) -- Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM), a leader in developing novel, controllable cellular immunotherapies for cancers and orphan inherited blood disorders, today [...]
Bone Therapeutics annonce les conclusions de l'analyse intermédiaire de l'étude de phase III avec PREOB dans l’ostéonécrose de la hanche
06/11/2018
Information réglementée – Information privilégiée Le DSMB recommande l'arrêt de l'essai clinique de phase III pour futilité Programmes de développement entièrement axés sur la plateforme ALLOB et JTA-004 Gosselies, [...]
LStar Imaging Selects eRAD to Launch Innovative Center
06/11/2018
Technology fits provider’s emphasis on next-level service GREENVILLE, S.C., Nov. 06, 2018 (GLOBE NEWSWIRE) -- eRAD announced today that LStar Imaging has selected a full suite of the company’s imaging workflow solutions [...]
Medtronic Presents IN.PACT SFA Trial Five-Year Data and Total IN.PACT All-Subjects Analysis in VIVA Late Breaking Clinical Trials
06/11/2018
New Data Continue to Reinforce IN.PACT Admiral DCB as a Durable, Frontline Option to Address Treatment Challenges in PAD DUBLIN and LAS VEGAS - November 6, 2018 - Medtronic plc (NYSE:MDT) data presented today reinforce [...]
Veritas Announces First Closing of Financing
06/11/2018
VANCOUVER, British Columbia, Nov. 06, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) ( “ Veritas ” or the “Company”) is pleased to announce the Closing of the Private Placement [...]
EssilorLuxottica : Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2018
06/11/2018
Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2018 (Pursuant to Article L.233-8 II of the French Commercial Code and articles 221-1 and 223-16 of the General Regulations of the Autorité des [...]
EssilorLuxottica : Nombre total de droits de vote et d'actions composant le capital social au 31 octobre 2018
06/11/2018
Nombre total de droits de vote et d'actions composant le capital social au 31 octobre 2018 (Conformément à l'article L.233-8 II du Code de Commerce et aux articles 221-1 et 223-16 du Règlement Général de l'AMF) [...]
SuperSonic Imagine to Introduce Aixplorer MACH 30 System for Non-Invasive Management of Liver Disease at The Liver Meeting 2018
06/11/2018
AIX-EN-PROVENCE, France, Nov. 06, 2018 (GLOBE NEWSWIRE) -- SuperSonic Imagine (Euronext: SSI, FR0010526814), a company specializing in ultrasound medical imaging, announced today it will be exhibiting at The Liver [...]
Abeona Therapeutics et REGENXBIO annoncent des licences mondiales exclusives pour le traitement de quatre maladies lysosomiales rares utilisant le vecteur NAV AAV9
06/11/2018
Abeona obtient de nouvelles licences pour NAV AAV9, pour le développement et la commercialisation de traitements de MPS IIIA, MPS IIIB et de la maladie de Batten CLN1 et CLN3 Abeona s'engage à verser un paiement initial [...]
Trading in Novo Nordisk shares by board members, executives and associated persons on 5 November 2018
06/11/2018
Bagsværd, Denmark, 6 November 2018 - This document discloses the data of the transaction(s) made in Novo Nordisk shares by the company's board members, executives and their associated persons in accordance with Article [...]
ICC Labs Announces Shareholder Approval of Arrangement With Aurora Cannabis
06/11/2018
VANCOUVER, British Columbia, Nov. 06, 2018 (GLOBE NEWSWIRE) -- ICC Labs Inc. (the Company or ICC ) (TSX-V: ICC) is pleased to announce that, at the special meeting of shareholders of ICC ( ICC Shareholders ) held today [...]

Pages